Overview

Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN)

Status:
Completed
Trial end date:
2021-06-07
Target enrollment:
Participant gender:
Summary
The main aim of this study is to determine the effects of short-term treatment with hesperidin on COVID-19 symptoms in comparison with a placebo. Treatment effects will be observed through a symptoms diary that will be completed by participants throughout the study and by taking the oral temperature daily.
Phase:
Phase 2
Details
Lead Sponsor:
Montreal Heart Institute
Collaborator:
Ingenew Pharmaceuticals Inc.